Clinical Trial: NRG GU010

NRG GU010

Status: Open

Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (GUIDANCE)

Eligible for screening study DCP 001